高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识

2021-09-08 中国防痨协会 中国防痨杂志. 2021,43(09)

主动发现和预防性治疗是全球终结结核病流行策略下,结核病防治行动的重要举措。我国是全球结核病高负担国家之一,要实现全球终止结核病目标,加强结核分枝杆菌潜伏感染(latent tuberculosis i

中文标题:

高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识

发布机构:

中国防痨协会

发布日期:

2021-09-08

简要介绍:

主动发现和预防性治疗是全球终结结核病流行策略下,结核病防治行动的重要举措。我国是全球结核病高负担国家之一,要实现全球终止结核病目标,加强结核分枝杆菌潜伏感染(latent tuberculosis infection,LTBI)者的主动发现,对结核病患者密切接触者进行筛查,对新近感染和免疫力低下LTBI人群给予预防性治疗,是降低LTBI者发病的重要措施。然而,当前业内人士对预防性治疗的适用对象、化学药物预防性治疗方案和预防性治疗效果尚存在较多疑虑和争议,同时,新的诊断技术和预防性治疗方法也在不断研究和应用。有鉴于此,中国防痨协会组织专家编写了《高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识》,从LTBI检测原理,以及预防性治疗对象、诊断方法、化学预防和免疫预防等方面进行论述,以供我国结核病防治工作者借鉴和参考。 
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识_周林.pdf)] GetToolGuiderByIdResponse(projectId=1, id=59d4d1c002185538, title=高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识, enTitle=, guiderFrom=中国防痨杂志. 2021,43(09), authorId=0, author=, summary=主动发现和预防性治疗是全球终结结核病流行策略下,结核病防治行动的重要举措。我国是全球结核病高负担国家之一,要实现全球终止结核病目标,加强结核分枝杆菌潜伏感染(latent tuberculosis i, cover=https://img.medsci.cn/2021914/1631562529091_2020535.jpg, journalId=0, articlesId=null, associationId=307, associationName=中国防痨协会, associationIntro=中国防痨协会成立于1933年10月21日,会址在上海。1950年从上海迁至北京,1953年8月在北京召开防痨工作者代表大会,70多年年来共召开了10次会员代表大会,先后由黄鼎臣、阚冠卿、戴志澄、张立兴、端木宏谨、王撷秀担任理事长。 协会编辑出版2种学术期刊,即《中国防痨杂志》和《国际结核病与肺部疾病杂志(中文版)》。1954年加入中国科协。1997年民政部关于社团清理整顿前,协会拥有全国及地方会员18000人,社团整顿后,中国防痨协会与各省、市、自治区地方防痨协会不存在垂直领导关系,但有业务指导关系,现全国31个省自治区直辖市均有防痨协会会员,现有会员近2000人,团体会员48个,3个专业委员会根据自己的专业特点,开展学术活动。, copyright=0, guiderPublishedTime=Wed Sep 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">主动发现和预防性治疗是全球终结结核病流行策略下,结核病防治行动的重要举措。我国是全球结核病高负担国家之一,要实现全球终止结核病目标,加强结核分枝杆菌潜伏感染(latent tuberculosis infection,LTBI)者的主动发现,对结核病患者密切接触者进行筛查,对新近感染和免疫力低下LTBI人群给予预防性治疗,是降低LTBI者发病的重要措施。然而,当前业内人士对预防性治疗的适用对象、化学药物预防性治疗方案和预防性治疗效果尚存在较多疑虑和争议,同时,新的诊断技术和预防性治疗方法也在不断研究和应用。有鉴于此,中国防痨协会组织专家编写了《高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识》,从LTBI检测原理,以及预防性治疗对象、诊断方法、化学预防和免疫预防等方面进行论述,以供我国结核病防治工作者借鉴和参考。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=9423, tagName=结核分枝杆菌)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9423, guiderKeyword=结核分枝杆菌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4416, appHits=211, showAppHits=0, pcHits=986, showPcHits=4204, likes=1, shares=24, comments=8, approvalStatus=1, publishedTime=Tue Sep 14 03:58:39 CST 2021, publishedTimeString=2021-09-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 14 03:48:58 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 03:09:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识_周林.pdf)])
高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识_周林.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1203462, encodeId=868a120346267, content=非常好的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Thu Mar 17 14:50:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180371, encodeId=a32711803e167, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4c52174354, createdName=1205bc4fm57(暂无昵称), createdTime=Tue Jan 04 12:32:28 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082386, encodeId=e8071082386c9, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:48:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077897, encodeId=ee0210e7897dd, content=很有实用性, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:41:21 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077881, encodeId=65d610e78813c, content=很实用👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:13:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-03-17 王隽ms6000000074992777

    非常好的资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1203462, encodeId=868a120346267, content=非常好的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Thu Mar 17 14:50:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180371, encodeId=a32711803e167, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4c52174354, createdName=1205bc4fm57(暂无昵称), createdTime=Tue Jan 04 12:32:28 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082386, encodeId=e8071082386c9, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:48:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077897, encodeId=ee0210e7897dd, content=很有实用性, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:41:21 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077881, encodeId=65d610e78813c, content=很实用👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:13:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-01-04 1205bc4fm57(暂无昵称)

    学习好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1203462, encodeId=868a120346267, content=非常好的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Thu Mar 17 14:50:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180371, encodeId=a32711803e167, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4c52174354, createdName=1205bc4fm57(暂无昵称), createdTime=Tue Jan 04 12:32:28 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082386, encodeId=e8071082386c9, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:48:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077897, encodeId=ee0210e7897dd, content=很有实用性, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:41:21 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077881, encodeId=65d610e78813c, content=很实用👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:13:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1203462, encodeId=868a120346267, content=非常好的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Thu Mar 17 14:50:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180371, encodeId=a32711803e167, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4c52174354, createdName=1205bc4fm57(暂无昵称), createdTime=Tue Jan 04 12:32:28 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082386, encodeId=e8071082386c9, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:48:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077897, encodeId=ee0210e7897dd, content=很有实用性, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:41:21 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077881, encodeId=65d610e78813c, content=很实用👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:13:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-07 ms3000000927114473

    很有实用性

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1203462, encodeId=868a120346267, content=非常好的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Thu Mar 17 14:50:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180371, encodeId=a32711803e167, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4c52174354, createdName=1205bc4fm57(暂无昵称), createdTime=Tue Jan 04 12:32:28 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082386, encodeId=e8071082386c9, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:48:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077897, encodeId=ee0210e7897dd, content=很有实用性, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:41:21 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077881, encodeId=65d610e78813c, content=很实用👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f0c5454303, createdName=ms3000000927114473, createdTime=Tue Dec 07 22:13:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-07 ms3000000927114473

    很实用👍👍👍

    0

拓展阅读

HIV合并结核分枝杆菌感染诊治专家共识

中华医学会感染病学分会艾滋病学组 · 2017-04-30

儿童结核分枝杆菌潜伏感染筛查和预防性治疗专家共识

中华医学会结核病学分会 · 2020-04-30

世界卫生组织《结核分枝杆菌耐药相关基因突变目录及其临床应用指南》解读

首都医科大学附属北京胸科医院细菌免疫室 · 2022-10-30

《结核分枝杆菌重组蛋白皮肤试验操作规范》解读

中国医学科学院/北京协和医学院病原生物学研究所 · 2022-12-15

《儿童结核分枝杆菌潜伏感染检测和预防性治疗》标准解读

首都医科大学附属北京友谊医院儿科 · 2023-01-04

《非结核分枝杆菌病诊断 》解读

同济大学附属上海市肺科医院结核科 · 2021-06-01